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LETTERS TO THE EDITOR 
The minimally invasive direct coronary artery by-
pass procedure: What is its future role? 
To the Editor: 
Doty and associates, 1 who pioneered the development of 
minimally invasive direct coronary artery bypass grafting 
(MIDCAB), described a series of 162 consecutive patients 
undergoing this procedure. It is important to put this series in 
perspective and clearly define the appropriate conclusions 
from this retrospective case report. 
First, the authors are to be commended for honestly report-
ing their postoperative morbidity and mortality in great detail. 
Because of this, these results will serve as an important bench-
mark for future experiences. The authors have demonstrated 
that selected patients can safely undergo a MIDCAB proce-
dure and that short-term follow-up indicates an acceptable 
relief of patients' symptoms. However, it is equally important 
to point out what carmot be concluded from this study. A 5% 
early mortality rate in these patients with limited coronary 
artery disease is high. On the basis of the demographic data 
provided, most surgeons would not consider this to be a par-
ticularly high-risk group. There is also a high incidence of 
myocardial infarction (4.2%) and wound infection (15%). 
Without either concomitant or historically matched controls, it 
is impossible to conclude whether the MIDCAB procedure 
actually reduces the mortality or even the morbidity of coro-
nary artery bypass grafting (CABG). Perhaps the greatest 
weakness of this study is the lack of angiographic follow-up. 
Unfortunately, very few of the patients underwent recatheteri-
zation (16.4%). Thus the critical question of graft patency after 
beating heart revascularization is not answered by this study. 
The precise role of the MIDCAB procedure is still waiting 
to be defined. MIDCAB is a field in evolution, in which tech-
niques are being continually refined and clinical results are 
improving. At present, the most critical issue is that of graft 
patency after beating heart surgery. It is imperative that this 
procedure have a patency rate comparable with that of tradi-
tional arrested heart cases. However, the "gold standard" for 
internal thoracic artery patency has not been established. In a 
previous report from The Cleveland Clinic, there was a report-
ed graft patency rate of 91.2%.2 Among 29 patients studied 
after more than 10 years, the patency rate of the left internal 
thoracic artery (LIT A) graft was 89.7%. In a recent interna-
tional multicenter randomized trial of 645 patients in which 
the LITA was anastomosed to the left anterior descending 
coronary artery (LAD), the LITA was widely patent in 91 % of 
patients.2,3 It has been established that at early and 6-month 
follow-up after MIDCAB, similar patency rates of 90% or 
greater can be achieved by using mechanical stabilization.4·7 
Although longer-term follow-up is needed, initial results are 
promising. With present technology, many surgeons now feel 
just as comfortable with their beating heart anastomoses as 
with those that they perform on the arrested heart. 
Despite the encouraging early patency results, it still has not 
been established whether the MIDCAB procedure significant-
ly reduces postoperative morbidity, the speed of postoperative 
recovery, or time to return to work. To determine the answer 
to these questions, there is a critical need for randomized tri-
als. The good news is that there are several randomized trials 
presently in progress. In this country, the POEM (Patency, 
Outcome and Economics of MIDCAB) Trial is presently 
underway. The end point is to evaluate 6-month angiographic 
patency and outcomes related to safety, efficacy, and event-
free survival in patients who undergo LIT A-LAD grafting 
through either a traditional median sternotomy or a MIDCAB 
procedure. Currently 9 sites are participating in this trial. 
In Europe, The Netherlands National Health Insurance 
Council has funded a multicenter study that began in March 
of 1998.9 This study involves 2 randomized trials. One trial 
will compare multivessel CABG without cardiopulmonary 
bypass using a mechanical tissue stabilizer versus conven-
tional CABG with cardiopulmonary bypass. The second trial 
will compare multivessel CABG without bypass using a sta-
bilizer versus stenting. Both trials will include angiographic 
follow-up at 1 year. 
With these data, it will soon be possible to determine both 
the benefits and the shortcomings of beating heart procedures. 
Until then, the widespread patient acceptance of these proce-
dures will continue to encourage the rapid progress in mini-
mally invasive cardiac surgery. The increasing number of 
beating heart cases being performed in this country would 
suggest that surgeons are becoming more comfortable and 
confident with these new procedures. As has been the case 
throughout surgical history, careful evaluation of clinical 
results will shape and direct this evolving new field. 
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Arch-first technique through left antero-axillary 
thoracotomy or bilateral anterior thoracotomy 
To the Editor: 
We read with great interest the article by Rokkas and 
Kouchoukos titled "Single-Stage Extensive Replacement of 
the Thoracic Aorta: The Arch-First Technique." They report 
that a bilateral thoracotomy enabled an arch-first reconstruc-
tion preceding proximal or distal aortic anastomosis, as well 
as retrograde cerebral perfusion tltrough the superior vena 
cava (SVC) for cerebral protection during deep hypothermic 
circulatory arrest in an extensive replacement of the thoracic 
aorta.! We totally agree with their strategy for reconstruction 
of the aortic arch. 
However, we do not believe that these techniques are orig-
inal with them. We have already advocated the use of a left 
antero-axillary thoracotomy, which is less invasive than a 
bilateral thoracotomy, as an alternative approach for aortic 
arch reconstruction.2,3 This type of thoracotomy combines the 
advantages of each approach, while filling a gap between a 
median sternotomy and posterolateral thoracotomy, by pro-
viding a wide view of the aortic arch from the ascending aorta 
to the mid-descending aorta and allowing access to the SVC 
for a retrograde cerebral perfusion during deep hypothermic 
circulatory arrest. Furthermore, the possibility for the prece-
dence of reconstruction of arch vessels through the left 
antero-axillary thoracotomy, and then the reperfusion to the 
arch vessels tltrough a side branch of the graft before anasto-
mosing the graft to the ascending aorta or descending aorta 
(which may shorten the period of cerebral ischemia), has 
already been explained in our article. 
A bilateral thoracotomy that requires a transverse sternoto-
my, ligation of both internal thoracic arteries, and entrance to 
both sides of the pleural cavities seems to be more invasive 
than a left antero-axillary thoracotomy. The pericardial stitch, 
which is placed at the corner of the pericardial reflection on 
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the SVC, can raise the SVC and pull out the ascending aorta 
toward the operative field, thus facilitating aortic and SVC 
cannulations even through a left antero-axillary thoracotomy.4 
Thus the arch-first technique tltrough a bilateral thoracoto-
my seems to achieve excellent results albeit with a far more 
extensive incision. 
Shiro Sasaguri, MD 
Tomonobu Fukuda, MD 




Tokyo, 113, Japan 
REFERENCES 
1. Rokkas CK, Kouchoukos NT. Single-stage extensive replacement 
of the thoracic aorta: the arch-first technique. J Thorac 
Cardiovasc Surg 1999;117:99-105. 
2. Sasaguri S, Yamamoto S, Fukuda T, Hosoda Y. Anteroaxillary tho-
racotomy facilitates the use of retrograde cerebral perfusion in dis-
tal aortic arch reconstruction. Ann Thorac Surg 1996;62: 1861-2. 
3. Sasaguri S, Yamamoto S, Fukuda T, Hosoda Y. Retrograde cere-
bral perfusion through antero-axillary thoracotomy in the aortic 
arch surgery. Eur J Cardiothorac Surg 1997;11:657-60. 
4. Sasaguri S, Fukuda T, Hosoda Y. Pericardiallift facilitates central 
cannulation in antero-axillary thoracotomy. Ann Thorac Surg 
1999;67 :597. 
12/8/98435 
Reply to the Editor: 
We appreciate the comments of Sasaguri and Fukuda. We 
did not claim in our publication that the techniques we used 
were original. In fact, we referred to previous use of the bilat-
eral thoracotomy approach,I.3 early antegrade cerebral perfu-
sion to minimize the period of circulatory arrest,4 as well as 
total replacement of the thoracic aorta in a single stage.2,3 We 
incorporated these techniques into a procedure that was used 
in patients who required extensive thoracic aortic resections, 
as well as aortic valve or root replacement and coronary 
artery bypass grafting. 
We are familiar with the reports of Sasaguri and his col-
leagues5,6 on the use of the left antero-axillary thoracotomy 
for aortic arch reconstruction. In their 1997 publication,6 they 
described and illustrated perfusion of the aortic arch after 
attachment of separate grafts to the 3 brachiocephalic arteries 
and to the aortic graft, but before completion of the proximal 
and distal aortic anastomoses. Our technique uses a single 
anastomosis to a cuff of aorta surrounding the brachiocephal-
ic arteries to minimize the duration of brain ischemia. They 
also indicated that disease requiring resection of the aorta 
below the level of the eighth thoracic vertebra should be 
approached tltrough a posterolateral thoracotomy.5,6 
In our series, which now includes 13 patients with 1 hospi-
tal death and no late deaths, the distal anastomosis of the aor-
tic graft to the thoracic aorta was performed at or below the 
junction of the middle and distal thirds of the descending tho-
racic aorta in 7 patients. In addition, 7 patients required aor-
tic valve or aortic root replacement or repair, and 6 required 
